Urethane-crosslinked biodegradable elastomers
Among other things, the present disclosure provides compositions and methods for an elastomeric cross-linked polyester material. Such an elastomeric cross-linked polyester material, in some embodiments, comprises a plurality of polymeric units of the general formula (-A-B—) p , wherein p is an integer greater than 1; and a plurality of urethane cross-links each of which covalently links two polymeric units to one another, which two linked polymeric unit each had at least one free hydroxyl or amino group prior to formation of the crosslink.
1. A patch comprising:
(1) an elastomeric cross-linked polyester material comprising:
a plurality of A and B components, wherein the A and B components form a plurality of polymeric backbones formed of (-A-B—) repeat units, having the general formula (-A-B—) p , wherein:
p is an integer greater than 1;
the (-A-B—) repeat units have a chemical structure produced by condensation of a polyol component A′ with a polyacid component B′;
wherein the A component of at least two of the (-A-B—) repeat units within each of the polymeric backbones has at least one free hydroxyl group present thereon, prior to crosslinking;
wherein crosslinking is carried out by a polyisocyanate crosslinker and the at least one free hydroxyl group to the polyisocyanate crosslinker is at a molar ratio of between 1:0.3 and 1:0.8;
wherein urethane cross-links covalently crosslink the polymeric backbones between the A components of the at least two (-A-B—) repeat units within each of the polymeric backbones; and
(2) a light activated adhesive;
wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 75%, about 80%, about 85%, about 90%, about 95%, or about 99%.
2. The patch of claim 1 , wherein the elastomeric cross-linked polyester material is in a non-porous film form.
3. The patch of claim 2 , wherein the non-porous film has a thickness of 200 μm.
4. The patch of claim 2 , wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 80%.
5. The patch of claim 2 , wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 85%.
6. The patch of claim 2 , wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 90%.
7. The patch of claim 2 , wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 95%.
8. The patch of claim 2 , wherein the elastomeric cross-linked polyester material has a light transmission percentage of more than about 99%.
9. The patch of claim 1 , wherein the elastomeric cross-linked polyester material comprises one or more agents selected from the group consisting of: therapeutic agents, cytotoxic agents, diagnostic agents, prophylactic agents, nutraceutical agents, and combinations thereof.
10. The patch of claim 1 , wherein the elastomeric cross-linked polyester material is non-linear.
11. The patch of claim 1 , wherein the elastomeric cross-linked polyester material has a molecular weight between about 3,000 and about 25,000 Daltons.
12. The patch of claim 1 , wherein the elastomeric cross-linked polyester material has one or more properties selected from the group consisting of:
a Young's modulus of between about 0.5 MPa and about 30 MPa;
a tensile strength of between about 0.5 MPa and about 15 MPa;
an elongation of between about 50% and about 600%;
a size deformation of below about 20% of its initial length, after tensile loading;
a tensile strength stable within about 5% to about 30% of the initial strength over 100 cycles of extension;
a size deformation stable within about 5% to about 30% of the initial length over 100 cycles of extension; and
combinations thereof.
13. The patch of claim 1 , wherein the patch is a medical patch for soft tissue defect repair.
14. The patch of claim 1 , wherein the soft tissue defect is a vascular defect, a cardiac defect, or a gastrointestinal defect.
15. The patch of claim 14 , wherein the gastrointestinal defect is an ulcer.
16. The patch of claim 1 , wherein the patch is attached to tissue by the light activated adhesive.
17. The patch of claim 1 , wherein the polyacid component B′ is selected from the group consisting of sebacic acid, succinic acid, fumaric acid, α-ketoglutaric acid, oxaloacetic acid, malic acid, oxalosuccinic acid, isocitric acid, cis-aconitic acid, citric acid, 2-hydroxy-malonic acid, tartaric acid, ribaric acid, arabanaric acid, xylaric acid, allaric acid, altraric acid, galacteric acid, glucaric acid, or mannaric acid, dimercaptosuccinic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, and azelaic acid.
18. The patch of claim 1 , wherein the polyol component A′ is selected from the group consisting of glycerol, erythritol, threitol, ribitol, arabinitol, xylitol, allitol, altritol, galactritol, sorbitol, mannitol, iditol, lactitol, isomalt, and maltitol.
19. A method of treating a soft tissue defect using the patch of claim 1 , comprising:
(1) attaching the patch of claim 1 to a soft tissue defect in a subject in need thereof; and
(2) activating the light activated adhesive to attach the patch to the soft tissue defect; wherein the patch is a medical patch for repairing the soft tissue defect.
20. The method of claim 19 , wherein the soft tissue defect is a tissue closure defect, a vascular defect, a cardiac defect, or a gastrointestinal defect.
21. The method of claim 20 , wherein the gastrointestinal defect is an ulcer.